AQUACEL® Ag+ Dressing Resources: See the Evidence
Download the clinical summary of newly published in vitro evidence1 demonstrating that the uniqueness of AQUACEL® Ag+ dressing is derived from the addition of two excipients: a chelator and a surfactant, designed to disrupt biofilm, helping the performance of ionic silver.1
It is the synergistic effect of these excipients, working for and with ionic silver,1 that sets apart the efficacy of this dressing to disrupt biofilm2 and kill infection-causing bacteria.*3,4
Watch the video on how biofilm delays wound healing and how AQUACEL® Ag+ dressings perform.
*As demonstrated in vitro
- Said J, Walker M, Parsons D, Stapleton P, Beezer A, Gaisford S, 2014. An in vitro test of the efficacy of an anti-biofilm wound dressing. International Journal of Pharmaceutics; 474:177-181.
- Physical Disruption of Biofilm by AQUACEL® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.
- Antimicrobial activity and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.
- Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.